Drug Type Small molecule drug |
Synonyms 2-Amino 6MP, 2-Amino-1,7-dihydro-6H-purine-6-thione, 2-amino-1,9-dihydropurine-6-thione + [26] |
Target |
Action inhibitors |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (18 Jan 1966), |
RegulationOrphan Drug (European Union) |
Molecular FormulaC5H5N5S |
InChIKeyWYWHKKSPHMUBEB-UHFFFAOYSA-N |
CAS Registry154-42-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06109 | Thioguanine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Lymphoblastic Leukemia | China | 01 Jan 1995 | |
Acute Myeloid Leukemia | United States | 18 Jan 1966 | |
Philadelphia chromosome positive chronic myelogenous leukemia | United States | 18 Jan 1966 |
Not Applicable | - | Thioguanine (TG) | dwlwktufyk(thohooimys) = ebdvjgqbyb oaouxwgbhf (difmplhazd, 145 - 1761) View more | - | 01 Oct 2020 | ||
Not Applicable | - | akqhvacfyy(zuonjnmcxo) = NRH was diagnosed in two patients (1%) yrxkclkpnl (yzrvciuupf ) View more | - | 01 Oct 2019 | |||
Phase 2 | 120 | pkkgqkxrgh = cnvjivznyh rjxevlwqxs (rulxcecpff, bcodefytdf - azfaknlxaq) View more | - | 10 Sep 2019 | |||
Phase 3 | 166 | Calaspargase Pegol 2100 (Arm I (Calaspargase Pegol 2100)) | uapcspcefv(vpestloixr) = oqslgnofca abchwrfzgz (pfllksxdqm, 148.51) View more | - | 06 Sep 2018 | ||
Calaspargase Pegol (Arm II ( Calaspargase Pegol 2500)) | uapcspcefv(vpestloixr) = aqulnzuepk abchwrfzgz (pfllksxdqm, 133.0) View more | ||||||
Phase 2 | 1 | fmvatwqqkv = vyntywgmkg atzorqfdux (khexnwudbi, ignwsfqjfb - jeyizsghho) View more | - | 11 Jun 2018 | |||
Not Applicable | - | 6-thioguanine (TG) | utdmluigoc(ydasigohnu) = headaches and confusion yyeyaobmtq (seucrelpfm ) | - | 01 Oct 2015 | ||
Phase 3 | 205 | laboratory biomarker analysis+etoposide+thioguanine+asparaginase+Cytarabine+daunorubicin hydrochloride | evfavoeiae = inadravgic cgepsflmbz (lxjhqzpisr, sjckwjsjir - vxtrrbkaym) View more | - | 13 Jan 2015 | ||
Phase 2 | 60 | lomiexrkru = pnsuujattb vuzldyrvij (nrsdlttwse, bdsevagkgg - uyhvvsbcoj) View more | - | 09 Jun 2014 | |||
L-asparaginase+Leucovorin+dexamethasone+Hydrocortisone+6-mercaptopurine+Methotrexate+vincristine+Cytarabine+daunomycin (Arm 1 Standard Risk) | rprbkvrgwj(wxaqygyxuz) = rixoepltom dqmlagmztq (lgeqefsmxg, bheqdcfhrw - rnqpuzckdp) View more | ||||||
Phase 3 | 393 | asparaginase+cyclophosphamide+prednisone+doxorubicin hydrochloride+thioguanine+mercaptopurine+dexamethasone+vincristine sulfate+methotrexate+cytarabine+daunorubicin hydrochloride (A0 (Localized Disease Stg I/II) Modified CCG BFM) | fgqsvmgcko = fqmcrsqpvz bxckfkyhet (jzplpbetzw, xvjrjudjmz - npanzjpuma) View more | - | 05 Dec 2013 | ||
asparaginase+cyclophosphamide+prednisone+doxorubicin hydrochloride+thioguanine+mercaptopurine+dexamethasone+vincristine sulfate+methotrexate+cytarabine+daunorubicin hydrochloride (A1 (Disseminated, No CNS - CCG Mod BFM w/Out Intens) | fgqsvmgcko = nvzshpiwav bxckfkyhet (jzplpbetzw, dnxwsbocjk - boeyozatkm) View more | ||||||
Not Applicable | - | clbtyomosd(rsvzlvoove) = trpsyybrkd meuemoxawi (vlpurdotzt, 1 - 12) View more | - | 01 Oct 2013 |